Markets
Tendies
@tendies
Bought MDAI
Shares
down -16.93%
At 3.13, Exited 2.6
The technical indicators for $MDAI are screaming bullish signals, especially with the upcoming golden cross. With strong fundamental catalysts and the...
Read
More
Thesis
The technical indicators for $MDAI are screaming bullish signals, especially with the upcoming golden cross. With strong fundamental catalysts and the stock being undervalued, I'm loading up for what could be a substantial move upwards as it gains more visibility.
Go back
Tendies
@tendies
Bought MDAI
Shares
down -5.8%
At 2.07, Exited 1.95
I've seen some fantastic growth in MDAI's latest financials, including a 138% revenue increase year-over-year and a significant improvement in gross m...
Read
More
Thesis
I've seen some fantastic growth in MDAI's latest financials, including a 138% revenue increase year-over-year and a significant improvement in gross margin. With key government contracts and operational milestones coming up, I'm feeling confident about holding this stock for the near future as it seems ripe for a rebound.
Go back
Tendies
@tendies
Bought MDAI
Shares
down -31.75%
At 2.11, Exited 1.44
I'm really confident in MDAI's potential due to their innovative machine learning algorithm that is set to receive FDA approval soon. With a valuable ...
Read
More
Thesis
I'm really confident in MDAI's potential due to their innovative machine learning algorithm that is set to receive FDA approval soon. With a valuable US government contract and strong market opportunities, I believe it's poised for significant growth in the long term!
Go back
Tendies
@tendies
Bought MDAI
Shares
down -18.08%
At 2.49, Exited 2.04
I believe that $MDAI is on the cusp of significant growth. With strong fundamentals, improved earnings, and upcoming study results, I'm banking on a r...
Read
More
Thesis
I believe that $MDAI is on the cusp of significant growth. With strong fundamentals, improved earnings, and upcoming study results, I'm banking on a rally in the share price as the market recognizes its potential, especially with NASDAQ listing coming up.
Go back
Tendies
@tendies
Bought MDAI
Shares
down -20.9%
At 1.34, Exited 1.06
I believe that $MDAI is primed for a significant move upward due to the upcoming spinoff and the potential short squeeze from the ongoing naked short ...
Read
More
Thesis
I believe that $MDAI is primed for a significant move upward due to the upcoming spinoff and the potential short squeeze from the ongoing naked short investigation. The combination of improving business fundamentals and this strategic spinoff gives me confidence that we could see a positive price action in the near future.
Go back
Tendies
@tendies
Bought MDAI
Shares
down -3.21%
At 1.56, Exited 1.51
Given the recent positive developments and the completion of the pivotal burn study ahead of schedule, I strongly believe MDAI is on the brink of sign...
Read
More
Thesis
Given the recent positive developments and the completion of the pivotal burn study ahead of schedule, I strongly believe MDAI is on the brink of significant gains. The upcoming topline results in December should attract attention, pushing the stock price above $2 by year-end.
Go back
Tendies
@tendies
Bought MDAI
Shares
up 24.89%
At 1.15, Exited 1.43
I've been closely following MDAI and I think this stock is set for a good swing opportunity. With their upcoming Q3 earnings and positive catalysts li...
Read
More
Thesis
I've been closely following MDAI and I think this stock is set for a good swing opportunity. With their upcoming Q3 earnings and positive catalysts like UK commercialization and FDA submissions, there's potential for substantial growth in the next few months. I'm ready to take a position.
Go back
Tendies
@tendies
Bought MDAI
Shares
up 1.2%
At 1.25, Exited 1.26
I'm betting on MDAI because I believe this stock is moving up ahead of their upcoming earnings report. The positive clinical results and potential com...
Read
More
Thesis
I'm betting on MDAI because I believe this stock is moving up ahead of their upcoming earnings report. The positive clinical results and potential commercialization numbers could push the price past $2 by the end of the year, especially after being oversold recently.
Go back
Tendies
@tendies
Bought MDAI
Shares
up 5.6%
At 0.95, Exited 1.0
I believe $MDAI is on the verge of a significant turnaround with strong fundamentals backing it up, and I see great potential for a price increase. Gi...
Read
More
Thesis
I believe $MDAI is on the verge of a significant turnaround with strong fundamentals backing it up, and I see great potential for a price increase. Given its current oversold status and upcoming catalysts, this stock can reach at least $2 by the end of the year, possibly even more.
Go back
Tendies
@tendies
Bought MDAI
Shares
down -6.18%
At 1.38, Exited 1.29
I'm optimistic about $MDAI's future, especially with its strong government support and upcoming catalysts that could significantly boost the share pri...
Read
More
Thesis
I'm optimistic about $MDAI's future, especially with its strong government support and upcoming catalysts that could significantly boost the share price. With a target of $3 by mid next year, it feels like a solid long-term investment given the company's current financial stability and potential growth prospects.
Go back
Tendies
@tendies
Bought MDAI
Shares
up 1.39%
At 1.44, Exited 1.46
I believe Spectral AI ($MDAI) has massive upside potential due to its innovative DeepView AI technology, which significantly outperforms traditional m...
Read
More
Thesis
I believe Spectral AI ($MDAI) has massive upside potential due to its innovative DeepView AI technology, which significantly outperforms traditional methods in diagnosing burn wounds and diabetic foot ulcers. With upcoming commercialization and strong insider support, this stock could see substantial appreciation as it gains market recognition.
Go back
